Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study
- PMID: 29898968
- DOI: 10.1212/WNL.0000000000005771
Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study
Abstract
Objective: To investigate the association between type 2 diabetes mellitus (T2DM) and subsequent Parkinson disease (PD).
Methods: Linked English national Hospital Episode Statistics and mortality data (1999-2011) were used to conduct a retrospective cohort study. A cohort of individuals admitted for hospital care with a coded diagnosis of T2DM was constructed, and compared to a reference cohort. Subsequent PD risk was estimated using Cox regression models. Individuals with a coded diagnosis of cerebrovascular disease, vascular parkinsonism, drug-induced parkinsonism, and normal pressure hydrocephalus were excluded from the analysis.
Results: A total of 2,017,115 individuals entered the T2DM cohort and 6,173,208 entered the reference cohort. There were significantly elevated rates of PD following T2DM (hazard ratio [HR] 1.32, 95% confidence interval [CI] 1.29-1.35; p < 0.001). The relative increase was greater in those with complicated T2DM (HR 1.49, 95% CI 1.42-1.56) and when comparing younger individuals (HR 3.81, 95% CI 2.84-5.11 in age group 25-44 years).
Conclusions: We report an increased rate of subsequent PD following T2DM in this large cohort study. These findings may reflect shared genetic predisposition and/or disrupted shared pathogenic pathways with potential clinical and therapeutic implications.
© 2018 American Academy of Neurology.
Comment in
-
Reader response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.Neurology. 2019 May 7;92(19):925. doi: 10.1212/WNL.0000000000007458. Neurology. 2019. PMID: 31061216 No abstract available.
-
Author response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.Neurology. 2019 May 7;92(19):925-926. doi: 10.1212/WNL.0000000000007459. Neurology. 2019. PMID: 31061217 No abstract available.
Similar articles
-
Prediabetes, type 2 diabetes mellitus and risk of Parkinson's disease: A population-based cohort study.Parkinsonism Relat Disord. 2021 Aug;89:22-27. doi: 10.1016/j.parkreldis.2021.06.002. Epub 2021 Jun 8. Parkinsonism Relat Disord. 2021. PMID: 34216937
-
Viral hepatitis and Parkinson disease: A national record-linkage study.Neurology. 2017 Apr 25;88(17):1630-1633. doi: 10.1212/WNL.0000000000003848. Epub 2017 Mar 29. Neurology. 2017. PMID: 28356465
-
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.Parkinsonism Relat Disord. 2012 Jul;18(6):753-8. doi: 10.1016/j.parkreldis.2012.03.010. Epub 2012 Apr 10. Parkinsonism Relat Disord. 2012. PMID: 22498320
-
Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998-2011: a retrospective national record linkage cohort study.Diabetologia. 2015 May;58(5):942-50. doi: 10.1007/s00125-015-3515-x. Epub 2015 Feb 12. Diabetologia. 2015. PMID: 25673256
-
A cohort study of age and sex specific risk of pyogenic liver abscess incidence in patients with type 2 diabetes mellitus.Medicine (Baltimore). 2019 Apr;98(17):e15366. doi: 10.1097/MD.0000000000015366. Medicine (Baltimore). 2019. PMID: 31027123 Free PMC article.
Cited by
-
Protein tyrosine phosphatase receptor type O serves as a key regulator of insulin resistance-induced α-synuclein aggregation in Parkinson's disease.Cell Mol Life Sci. 2024 Sep 14;81(1):403. doi: 10.1007/s00018-024-05436-4. Cell Mol Life Sci. 2024. PMID: 39276174 Free PMC article.
-
Parkinson's disease is associated with clonal hematopoiesis with TET2 mutation.NPJ Parkinsons Dis. 2024 Sep 6;10(1):168. doi: 10.1038/s41531-024-00784-1. NPJ Parkinsons Dis. 2024. PMID: 39242596 Free PMC article.
-
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis.J Neuroimmune Pharmacol. 2024 Jul 23;19(1):36. doi: 10.1007/s11481-024-10142-w. J Neuroimmune Pharmacol. 2024. PMID: 39042202
-
Frailty and Parkinson's disease: the role of diabetes mellitus.Front Med (Lausanne). 2024 May 30;11:1377975. doi: 10.3389/fmed.2024.1377975. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38882667 Free PMC article. Review.
-
The Parkinson's Story of a Neurologist with 32 Years of Experience on Parkinson's Disease.Noro Psikiyatr Ars. 2024 May 27;61(2):175-179. doi: 10.29399/npa.28634. eCollection 2024. Noro Psikiyatr Ars. 2024. PMID: 38868853 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases